Covered recipient · General Payments record
EDWIN FIGUEROA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,714.44
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $208.26 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $80.50 | 5 |
| Acerta Pharma LLC | $36.30 | 2 |
| Phadia US Inc. | $24.87 | 1 |
| Lilly USA, LLC | $22.08 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.43 | 1 |
| Exact Sciences Corporation | $14.72 | 1 |
| Amgen Inc. | $13.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $13.36 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117553293 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.69 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105799316 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.61 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105730087 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.43 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118199998 | CMS |
| Exact Sciences Corporation | $14.72 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114657120 | CMS |
| Lilly USA, LLC | $22.08 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135614823 | CMS |
| Novo Nordisk Inc | $21.81 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100347730 | CMS |
| Novo Nordisk Inc | $15.77 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100265012 | CMS |
| Novo Nordisk Inc | $15.15 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100465358 | CMS |
| Novo Nordisk Inc | $13.97 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100504245 | CMS |
| Novo Nordisk Inc | $13.80 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100551070 | CMS |
| Phadia US Inc. | $24.87 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067578262 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.